Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-24

FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the diclofenac sodium and misoprostol product from Mylan Pharmaceuticals, updating its labeling under an existin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac sodium and misoprostol (diclofenac sodium and misoprostol)

Snippet

SUPPL AP for DICLOFENAC SODIUM AND MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL)